Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019 at 3:30pm Pacific time / 6:30pm Eastern time.
BRAINTREE, Mass., /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019 at 3:30pm Pacific time / 6:30pm Eastern time. The public may access Mr. Simon's presentation live via webcast at: https://jpmorgan.metameetings.net/events/healthcare19/sessions/23877-haemonetics-corporation/webcast ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.
SOURCE Haemonetics Corporation |
||||||||||||||||||
Company Codes: NYSE:HAE |